Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.4 USD | +0.51% | +0.60% | +14.95% |
04-26 | Wolfe Adjusts Price Target on Xylem to $145 From $143 | MT |
04-22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.83 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.8 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.95% | 31.6B | A | ||
+12.62% | 82.74B | A- | ||
+18.07% | 69.97B | B | ||
+19.58% | 37.66B | B- | ||
+12.35% | 27.79B | B- | ||
+2.58% | 26.5B | C+ | ||
+17.57% | 25.66B | B+ | ||
+2.11% | 25.43B | B+ | ||
+15.74% | 24.64B | B | ||
+17.40% | 17.82B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- XYL Stock
- Ratings Xylem Inc.